Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 18 lat lub starsi, wszystkich ras i etnicznych pochodzeń
- •Diagnoza zaawansowanego raka prostaty, który rozprzestrzenił się na inne części ciała
- •Planowany początek nowego leczenia systemowego (pierwsze lub kolejne podejście)
- •Wcześniejszy udział w innych badaniach klinicznych jest dozwolony
✗ Disqualifies
- •Niemożność udzielenia świadomej zgody
- •Inny nowotwór, chyba że był leczony z zamiarem całkowitego wyleczenia i pacjent był wolny od choroby przez co najmniej 3 lata
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 8, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (2)
Los Angeles General Medical Center
Los Angeles, United States
USC / Norris Comprehensive Cancer Center
Los Angeles, United States
Trial contact
Cheryl Kefauver, RN
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.